Epidemiologische Untersuchungen zur Häufigkeit des Analgetika-Abusus

Autor: J Walter-Sack, G Küster, E Ritz, P F Rieser, J X de Vries, R Waldherr, T Mohr

Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 115:129-132

To assess the epidemiology of habitual use of analgesics in South-West Germany (i) urine specimens of employees of a factory, of patients seen by a general practitioner (GP) and of patients attending a renal clinic were examined for paracetamol; (ii)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b6182f771ec4731246063072da10b90
https://doi.org/10.1055/s-2008-1064981

Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients.

Autor: Hu, Lin¹ (AUTHOR) 1150721071@qq.com, Huang, Shiqiong¹ (AUTHOR), Huang, Qi² (AUTHOR), Huang, Juanjuan¹ (AUTHOR), Feng, Zeying^3,4 (AUTHOR), He, Gefei¹ (AUTHOR) 1150721071@qq.com

Publikováno v: PLoS ONE. 9/11/2023, Vol. 18 Issue 9, p1-12. 12p.

Factors Influencing Blood Concentration of Voriconazole and Therapeutic Drug Monitoring in Patients with Child–Pugh Class C Cirrhosis.

Autor: Zhang, Ying¹, Wu, Rongrong², Liu, Fangfang³, Wang, Yonggang⁴, Zhang, Junchang⁴, Ji, Chengcheng⁴, Lu, Xianghong⁴, Chang, Dan⁴, Mu, Jinsong⁴

Publikováno v: Journal of Clinical Pharmacy & Therapeutics. 2/14/2023, p1-10. 10p.

Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism.

Autor: Masako Ishida, Takeshi Kumagai, Tatsuro Yamamoto, Hiroyuki Suzuki, Kuniaki Moriki, Masachika Fujiyoshi, Kiyoshi Nagata, Miki Shimada

Publikováno v: Yonago Acta Medica; 2024, Vol. 67 Issue 1, p1-40, 10p

Interaction of age and CYP2C19 genotypes on voriconazole steady-state trough concentration in Chinese patients.

Autor: Du YX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan., Zhu YX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan., Li L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan., Yang J; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Chen XP; Department of Clinical Pharmacology, Xiangya Hospital, Central South University.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan.

Publikováno v: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2024 Aug 01; Vol. 34 (6), pp. 191-198. Date of Electronic Publication: 2024 May 15.